CHZ868, CAS 1895895-38-1

Product Description: CHZ868 is a type II JAK2 inhibitor with an IC50 of 0.17 μM in EPOR JAK2 WT Ba/F3 cell.

Applications: Cancer-Kinase/protease

Formula: C22H19F2N5O2

References: [1]Meyer SC, et al. CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer Cell. 2015 Jul 13;28(1):15-28./[2]Wu SC, et al. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2015 Jul 13;28(1):29-41.

CAS Number: 1895895-38-1

Molecular Weight: 423.42

Compound Purity: 99.56

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: JAK

• Artikelnummer: MEXHY-18960-1G
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-18960-1G
• Verpackungseinheit: 1 g
• Mengeneinheit: STK